BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18580471)

  • 1. Blood monitoring of granzyme B and perforin expression after intestinal transplantation: considerations on clinical relevance.
    Altimari A; Gruppioni E; Capizzi E; Bagni A; Corti B; Fiorentino M; Lazzarotto T; Lauro A; Pinna AD; Ridolfi L; Grigioni WF; D'errico-Grigioni A
    Transplantation; 2008 Jun; 85(12):1778-83. PubMed ID: 18580471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary cytotoxic molecular markers for a noninvasive diagnosis in acute renal transplant rejection.
    Yannaraki M; Rebibou JM; Ducloux D; Saas P; Duperrier A; Felix S; Rifle G; Chalopin JM; Hervé P; Tiberghien P; Ferrand C
    Transpl Int; 2006 Sep; 19(9):759-68. PubMed ID: 16918537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Perforin and granzyme B as an early indicator for acute rejection of pancreatic transplantation].
    Zhang G; Han FH; Zhang ZD; Hu WM; Ke NW; Zhou X; Lu HM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Nov; 39(6):957-61. PubMed ID: 19253835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CMV, EBV, HHV6, and HHV7 infections after intestinal transplantation without specific antiviral prophylaxis.
    Pascher A; Klupp J; Schulz RJ; Dignass A; Neuhaus P
    Transplant Proc; 2004 Mar; 36(2):381-2. PubMed ID: 15050166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perforin, Granzyme B, and fas ligand for molecular diagnosis of acute renal-allograft rejection: analyses on serial biopsies suggest methodological issues.
    Graziotto R; Del Prete D; Rigotti P; Anglani F; Baldan N; Furian L; Valente M; Antonello A; Marchini F; D'Angelo A; Gambaro G
    Transplantation; 2006 Apr; 81(8):1125-32. PubMed ID: 16641597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two years' experience of acute rejection monitoring of intestinal transplant recipients by real-time PCR assessment of granzyme B and perforin up-regulation: considerations on diagnostic accuracy.
    Corti B; Altimari A; Gabusi E; Pinna AD; Gruppioni E; Lauro A; Pirini MG; Fiorentino M; Ridolfi L; Grigioni WF; Grigioni AD
    Transplant Proc; 2006; 38(6):1726-7. PubMed ID: 16908262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of serum and whole blood levels of cytomegalovirus and Epstein-Barr virus DNA.
    Kullberg-Lindh C; Olofsson S; Brune M; Lindh M
    Transpl Infect Dis; 2008 Oct; 10(5):308-15. PubMed ID: 18466193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional profiles in urine during acute rejection, bacteriuria, CMV infection and stable graft function after renal transplantation.
    Øzbay A; Tørring C; Olsen R; Carstens J
    Scand J Immunol; 2009 Apr; 69(4):357-65. PubMed ID: 19284501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of acute renal allograft rejection by analyzing whole blood mRNA expression of lymphocyte marker molecules.
    Alakulppi NS; Kyllönen LE; Partanen J; Salmela KT; Laine JT
    Transplantation; 2007 Mar; 83(6):791-8. PubMed ID: 17414714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous monitoring by real-time polymerase chain reaction of epstein-barr virus, human cytomegalovirus, and human herpesvirus-6 in juvenile and adult liver transplant recipients.
    Ono Y; Ito Y; Kaneko K; Shibata-Watanabe Y; Tainaka T; Sumida W; Nakamura T; Kamei H; Kiuchi T; Ando H; Kimura H
    Transplant Proc; 2008 Dec; 40(10):3578-82. PubMed ID: 19100443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential of real-time PCR assessment of granzyme B and perforin up-regulation for rejection monitoring in intestinal transplant recipients.
    Corti B; Altimari A; Gabusi E; Pinna AD; Lauro A; Morselli-Labate AM; Gruppioni E; Pirini MG; Fiorentino M; Ridolfi L; Grigioni WF; D'Errico-Grigioni A
    Transplant Proc; 2005 Dec; 37(10):4467-71. PubMed ID: 16387147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The experimental research on the perforin and granzyme B expressions to the early diagnostic value of acute rejection response after pancreatic transplantation].
    Hu WM; Zhang ZD; Han FH; Zhou X; Meng LX; Ke NW
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):88-92. PubMed ID: 17294736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
    J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease.
    Manuel O; Asberg A; Pang X; Rollag H; Emery VC; Preiksaitis JK; Kumar D; Pescovitz MD; Bignamini AA; Hartmann A; Jardine AG; Humar A
    Clin Infect Dis; 2009 Oct; 49(8):1160-6. PubMed ID: 19751151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained Epstein-Barr virus detection in paediatric liver transplantation. Insights into the occurrence of late PTLD.
    D'Antiga L; Del Rizzo M; Mengoli C; Cillo U; Guariso G; Zancan L
    Liver Transpl; 2007 Mar; 13(3):343-8. PubMed ID: 17154402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive diagnosis of cellular and antibody-mediated rejection by perforin and granzyme B in renal allografts.
    Veale JL; Liang LW; Zhang Q; Gjertson DW; Du Z; Bloomquist EW; Jia J; Qian L; Wilkinson AH; Danovitch GM; Pham PT; Rosenthal JT; Lassman CR; Braun J; Reed EF; Gritsch HA
    Hum Immunol; 2006 Oct; 67(10):777-86. PubMed ID: 17055354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Perforin and granzyme B expression in liver allograft rejection].
    Ji J; Yu YY; Chen H; Deng XX; Shen BY; Zhou GW; Peng CW; Li HW
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):325-7. PubMed ID: 15225420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute cellular rejection monitoring after intestinal transplant: utility of serologic markers and zoom videoendoscopy as support of conventional biopsy and clinical findings.
    Lauro A; Altimari A; Di Simone M; Dazzi A; Cescon M; Zanfi C; Miklosova Z; Corti B; Gruppioni E; D'Errico A; Cautero N; Giustozzi G; Ansaloni L; Ramacciato G; Gruttadauria S; Gruttadauria G; Pinna AD
    Transplant Proc; 2008 Jun; 40(5):1575-6. PubMed ID: 18589154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of different biomarkers provides valuable diagnostic standards in the evaluation of the risk of acute rejection.
    Zheng J; Ding X; Tian X; Jin Z; Pan X; Yan H; Feng X; Hou J; Xiang H; Ren L; Tian P; Xue W
    Acta Biochim Biophys Sin (Shanghai); 2012 Sep; 44(9):730-6. PubMed ID: 22759804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between elevated whole blood Epstein-Barr virus (EBV)-encoded RNA EBV polymerase chain reaction and reduced incidence of acute lung allograft rejection.
    Ahya VN; Douglas LP; Andreadis C; Arnoldi S; Svoboda J; Kotloff RM; Hadjiliadis D; Sager JS; Woo YJ; Pochettino A; Schuster SJ; Stadtmauer EA; Tsai DE
    J Heart Lung Transplant; 2007 Aug; 26(8):839-44. PubMed ID: 17692789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.